The increase of α-synuclein and alterations of dynein in A53T transgenic and aging mouse. (February 2022)

• Record Type: Journal Article
• Authors: Wang, Yiqing; Sun, Zhenjie; Du, Shouyun; Wei, Hongyu; Li, Xiuming; Li, Xiaojing; Shen, Jiahui; Chen, Xinya; Cai, Zenglin
• Is Part Of: Journal of clinical neuroscience. Volume 96(2022)
• Page Start: 154
• Page End: 162
• Publication Date: 2022-02
• Subjects: Dynein -- Aging -- α-Synuclein -- Parkinson's disease (PD) -- Autophagy; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2021.11.002
• Languages: English
• ISSNs: 0967-5868

Abstract

Abstract: The dynein protein plays a key role in the degradation pathway by attaching to targeted molecules and transporting the autophagosome to the centrosome. Aging plays an important role in the pathogenesis of Parkinson's disease (PD), but its effect on dynein is not clear. In this study we analyzed behavioral characteristics using the rod endurance test and climbing rod time test in different aged mice (3 months, 12 months, 20 months), and measured protein expression of dynein, α-synuclein, Tctex-1, and LC3 in the substantia nigra of the mice by Western blot. The mRNA levels of dynein, α-synuclein, LC3 and Tctex-1 were measured by quantitative real time reverse transcription PCR, and detecting expression of dynein and α-synuclein by immunofluorescence. We found the motor functions of A53T mutant mice, in 12 months and 20 months, decreased more significantly compared with normal mice (p < 0.05). In addition, the expression of dynein, LC3-Ⅱ and Tctex-1 proteins in the substantia nigra of the two groups decreased with age. However, α-synuclein protein increased gradually with age, with significantly higher levels in the PD groups compared with age matched controls (p < 0.05). These results were confirmed by immunofluorescence. Our data demonstrates that dynein and other autophagy proteins change with age, and this is associated with increased α-synuclein. Therefore, therapeutics that prevent dynein dysfunction may offer novel treatments for PD and other autophagy related diseases.